Search

Rodney A Prell

from Oakland, CA
Age ~58
Get Report
Also known as:
Rodney Dr Prell, Rodney Allen Prell, Rodney Te Prell, Rodney Brell
Related to:
Ann M Prell, 86Howard D Prell, 88Steven J Prell, 60
Connected to:
Allan V Prell, 87Amber H Prell, 29Brandon D Prell, 43Hans P Prell, 46Jerry D Prell, 44Joseph M Prell, 63Ruth A Prell, 74Ellen D Prelle, 77Eric A Prelle, 40

Rodney Prell Phones & Addresses

  • Oakland, CA
  • 838 33Rd St, Richmond, CA 94804
  • San Pablo, CA
  • Gresham, OR
  • Corvallis, OR
  • Iron River, WI
  • Gresham, OR

Resumes

Resumes

Rodney Prell Photo 1

Staff Scientist And Toxicologist Cancer Immunology Therapeutic Area Lead

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Genentech
Staff Scientist and Toxicologist Cancer Immunology Therapeutic Area Lead
Genentech Oct 2015 - Jan 2019
Principal Scientist and Toxicologist; Cancer Immunotherapy Area Lead
Genentech Jun 2012 - Oct 2015
Senior Scientist and Toxicologist; Immuno-Oncology Therapeutic Area Lead
Genentech Nov 2007 - Jun 2012
Scientist and Toxicologist
Cerus 2004 - 2007
Senior Scientist and Manager
Education:
Oregon State University 1991 - 1997
Doctorates, Doctor of Philosophy, Toxicology, Philosophy
Skills:
Biotechnology
Drug Development
Biopharmaceuticals
Oncology
Life Sciences
Cell Biology
Immunology
Assay Development
Cell
Cancer Immunotherapy
Cell Culture
Drug Discovery
Molecular Biology
Pharmaceutical Industry
Certifications:
Dabt
Rodney Prell Photo 2

Senior Scientist And Manager In Vivo Biology

View page
Location:
Richmond, CA
Industry:
Biotechnology
Work:
Cerus
Senior Scientist and Manager In Vivo Biology
Cell Genesys Jan 2002 - Nov 2004
Scientis Ii and Iii
Onyx Pharmaceuticals Mar 2001 - Dec 2001
Scientist Ii
Education:
Oregon State University 1991 - 1997
Doctorates, Doctor of Philosophy, Toxicology University of Wisconsin - Madison 1985 - 1989
Bachelors, Bachelor of Science, Biochemistry

Publications

Us Patents

Cytokine-Expressing Cellular Vaccine Combinations

View page
US Patent:
20050002916, Jan 6, 2005
Filed:
Mar 24, 2004
Appl. No.:
10/807449
Inventors:
Karin Jooss - Bellevue WA, US
Jennifer Creson - San Mateo CA, US
Betty Li - San Francisco CA, US
Rodney Prell - Richmond CA, US
Sandra Aung - San Francisco CA, US
Marina Moskalenko - Pacifica CA, US
Thomas Du - Newark CA, US
International Classification:
A61K048/00
A61K038/21
A61K039/395
A61K031/704
A61K031/337
US Classification:
424093210, 424144100, 424085700, 514034000, 514449000
Abstract:
The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the administration of the combination of a cytokine-expressing cellular vaccine and at least one additional cancer therapeutic agent or treatment to a patient with cancer, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of the cytokine-expressing cellular vaccine or cancer therapeutic agent or treatment as a monotherapy.

Cytokine-Expressing Cellular Vaccine Combinations

View page
US Patent:
20120034242, Feb 9, 2012
Filed:
Jul 12, 2011
Appl. No.:
13/180644
Inventors:
Karin Jooss - Bellevue WA, US
Jennifer Creson - San Mateo CA, US
Betty Li - San Francisco CA, US
Rodney Prell - Richmond CA, US
Sandra Aung - San Francisco CA, US
Marina Boris Moskalenko - Pacifica CA, US
Thomas Du - Newark CA, US
Assignee:
BIOSANTE PHARMACEUTICALS, INC. - LINCOLNSHIRE IL
International Classification:
A61K 39/395
A61P 37/04
A61P 35/00
A61K 39/00
A61K 41/00
US Classification:
4241731, 4242771
Abstract:
The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the administration of the combination of a cytokine-expressing cellular vaccine and at least one additional cancer therapeutic agent or treatment to a patient with cancer, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of the cytokine-expressing cellular vaccine or cancer therapeutic agent or treatment as a monotherapy.

Cytokine-Expressing Cellular Vaccine Combinations

View page
US Patent:
20040197312, Oct 7, 2004
Filed:
Apr 2, 2003
Appl. No.:
10/404662
Inventors:
Marina Moskalenko - Pacifica CA, US
Betty Li - San Francisco CA, US
Sandra Aung - San Francisco CA, US
Rodney Prell - Richmond CA, US
Jennifer Creson - San Mateo CA, US
Karin Jooss - San Francisco CA, US
International Classification:
A61K048/00
A61K039/395
A61K038/19
US Classification:
424/093210, 424/145100, 424/085100
Abstract:
The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the administration of the combination of a cytokine-expressing cellular vaccine and at least one additional cancer therapeutic agent or treatment to a patient with cancer, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of components thereof as a monotherapy.
Control profile
Rodney A Prell from Oakland, CA, age ~58 Get Report